Antiepileptic Drugs and Osteoporotic Prevention Trial
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
Study Design: (e.g., Controlled, Double-Blind, Randomized, Parallel):
Randomized, double-blind, placebo controlled of a bisphosphonate in the prevention of bone
loss associated with the use of antiepileptic drugs.
Phase:
Phase 4
Details
Lead Sponsor:
Boston VA Research Institute, Inc.
Collaborators:
Alliance for Better Bone Health Procter and Gamble VA Boston Healthcare System